Medtronic Payment for (Proceeds from) Other Investing Activity decreased by 9.4% to $125.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 635.3%, from $17.00M to $125.00M.
Fluctuations are typically non-recurring; large values may warrant investigation into specific one-time events.
This captures miscellaneous cash flows related to investing activities that do not fit into standard categories like pro...
Standard line item in cash flow statements for miscellaneous investing adjustments.
investing_payments_for_proceeds_from_other_investing_activities| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.00M | -$95.00M | $90.00M | -$30.00M | $89.00M | -$74.00M | $17.00M | -$18.00M | $156.00M | $106.00M | $17.00M | -$31.00M | $125.00M | $138.00M | $125.00M |
| QoQ Change | — | -225.0% | +194.7% | -133.3% | +396.7% | -183.1% | +123.0% | -205.9% | +966.7% | -32.1% | -84.0% | -282.4% | +503.2% | +10.4% | -9.4% |
| YoY Change | — | — | — | -139.5% | +193.7% | -182.2% | +156.7% | -120.2% | +310.8% | — | +0.0% | -72.2% | -19.9% | +30.2% | +635.3% |